Breaking News Instant updates and real-time market news.

MDT

Medtronic

$78.90

-0.59 (-0.74%)

, LOW

Lowe's

$81.46

1.24 (1.55%)

20:25
11/20/17
11/20
20:25
11/20/17
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Medtronic (MDT), consensus 99c... Lowe's (LOW), consensus $1.02... Analog Devices (ADI), consensus $1.36... Dollar Tree (DLTR), consensus 90c... Hormel Foods (HRL), consensus 40c... Campbell Soup (CPB), consensus 97c... Burlington Stores (BURL), consensus 65c... Signet Jewelers (SIG), consensus 10c... DSW (DSW), consensus 53c.

MDT

Medtronic

$78.90

-0.59 (-0.74%)

LOW

Lowe's

$81.46

1.24 (1.55%)

ADI

Analog Devices

$93.07

2.65 (2.93%)

DLTR

Dollar Tree

$97.11

2.5 (2.64%)

HRL

Hormel Foods

$33.40

0.28 (0.85%)

CPB

Campbell Soup

$49.93

0.21 (0.42%)

BURL

Burlington Stores

$106.55

1.82 (1.74%)

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

DSW

DSW

$22.53

0.38 (1.72%)

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 27

    Nov

  • 01

    Dec

  • 09

    Jan

  • 23

    Jan

  • 24

    Jan

MDT Medtronic
$78.90

-0.59 (-0.74%)

11/20/17
RHCO
11/20/17
NO CHANGE
Target $92
RHCO
Buy
Medtronic price target lowered to $92 from $96 at SunTrust
SunTrust analyst Bruce Nudell lowered his price target on Medtronic to $92 and kept his Buy rating. Nudell is modelling Q2 hurricane impact of about $59M relative to $55M-$65M guidance along with a less favorable FX adjustment of negative $18M. The analyst says he will monitor for an update on any expected residual storm impact for the rest of the year as well as any color on the company's new product pipeline.
10/10/17
NEED
10/10/17
NO CHANGE
Target $94
NEED
Buy
Medtronic shares remain attractive despite hurricane impact, says Needham
Needham analyst Mike Matson lowered his price target on Medtronic to $94 from $95 to account for about $250M estimated negative impact from Puerto Rico manufacturing disruption due to Hurricane Maria. However, the analyst views the impact as temporary, maintaining his Buy rating given the large discount in stock price that Matson sees relative to peers. He also notes that reports of the company's "product cycle demise have been greatly exaggerated" and remains confident that Medtronic can sustain a mid-single digit revenue growth rate.
10/16/17
SBSH
10/16/17
NO CHANGE
Target $359.33
SBSH
Buy
TransEnterix not 'in the same league' as Intuitive Surgical, says Citi
Citi analyst Amit Hazan believes Friday's FDA approval of TransEnterix's (TRXC) Senhance Surgical Robotic System should be viewed far less in the context of a competitive threat to Intuitive Surgical's (ISRG) da Vinci and more of another sign that the FDA has "eased its bar" for approval. The TransEnterix Senhance system is "at least currently not in the same league as da Vinci," Hazan tells investors in a research note titled "Intuitive's First US Competitor Arrives, Sort Of." He admits, however, that Intuitive is increasingly likely to see new competition, from Medtronic (MDT) first and then Johnson & Johnson's (JNJ) joint venture "much later," on time or earlier than expected. Hazan still expects Intuitive to dominate, however, and keeps a Buy rating on the shares. The stock sold off 3% in after-hours trading on Friday following TransEnterix's announcement.
10/10/17
BMOC
10/10/17
NO CHANGE
Target $89
BMOC
Outperform
BMO sees $250M impact on Medtronic from hurricane manufacturing disruption
BMO Capital analyst Joanne Wuensch lowered her price target for Medtronic to $89 from $92, modeling a $250M impact on manufacturing in Puerto Rico resulting from Hurricane Maria. Wuensch notes that most of the impact will occur in Q2 of FY18, also lowering her EPS target for the year to $4.63 from $4.78. The analyst kept her Outperform rating on the stock.
LOW Lowe's
$81.46

1.24 (1.55%)

11/06/17
KEYB
11/06/17
INITIATION
Target $98
KEYB
Overweight
Lowe's initiated with an Overweight at KeyBanc
KeyBanc analyst Bradley Thomas initiated Lowe's with an Overweight and $98 price target telling investors the company is positioned for improved execution in marketing and the labor model transition, combined with a more favorable industry backdrop. Further, the analyst expects the appliances category to continue to gain share and for new price optimization to support margins.
11/07/17
11/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Michael Kors (KORS) resumed with a Neutral at BofA/Merrill. 2. Lowe's (LOW) was initiated with an Overweight at KeyBanc while Home Depot (HD) was initiated with a Sector Weight. 3. OptiNose (OPTN) was initiated with an Outperform at BMO Capital and RBC Capital, an Overweight at Piper Jaffray, and a Buy at Jefferies. 4. LendingClub (LC) initiated with a Buy at Maxim. 5. LKQ Corp. (LKQ) initiated with an Outperform at Wolfe Research. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/02/17
CLVD
11/02/17
NO CHANGE
CLVD
Amazon gaining traction in building products, says Cleveland Research
Cleveland Research said its work suggests Amazon (AMZN) is continuing with its "meaningful" effort to grow its penetration in building product categories and the firm sees potential for its progress to accelerate. Additionally, the firm has heard Amazon is starting to measure its B2B base for pro contractors and remodelers and channel respondents think Amazon could take share in building products. The firm sees Home Depot (HD) as "incrementally proactive" in addressing online competition and continues to see uneven execution impacting Lowe's (LOW). However, its channel work pointed to some progress from Lowe's on inventory and service, the firm noted.
11/02/17
BARD
11/02/17
NO CHANGE
BARD
Outperform
Baird says Home Depot, Lowe's weakness on Amazon worries a buying opportunity
Baird analyst Peter Benedict attributes today's weakness in shares of Home Depot (HD) and Lowe's (LOW) to a competing research firm's note discussing Amazon's (AMZN) efforts to serve professional customers of building products. While he would "never dismiss" Amazon, Benedict believes both Home Depot and Lowe's are well positioned to compete and he views the weakness as a buying opportunity. The analyst reiterates his Outperform rating on both stocks, keeping a $175 price target on Home Depot and a $87 target on Lowe's.
ADI Analog Devices
$93.07

2.65 (2.93%)

09/12/17
JPMS
09/12/17
NO CHANGE
JPMS
JPMorgan lays out iPhone content winners and losers into launch event
JPMorgan analyst Harlan Sur believes Apple's (AAPL) launch event today will be positive for Broadcom (AVGO) and Qorvo (QRVO) as well as Micron (MU) and Intel (INTC). The analyst sees content gains by Broadcom in wireless charging, touch controller, Wi-Fi/Bluetooth and GPS connectivity, and by Qorvo in low band power amplifier duplexers share and antenna tuning. Other companies with significant Apple exposure that would benefit from increased unit sales and/or modest content gains include Intel, Skyworks (SWKS), Knowles (KN), Micron, Cypress Semiconductor (CY), NXP Semiconductors (NXPI) and Texas Instruments (TXN), Sur tells investors in a research note. The analyst sees Analog Devices' (ADI) blended content at Apple declining as he believes the company will not be the touch controller for the OLED-version of the iPhone.
09/18/17
MSCO
09/18/17
NO CHANGE
MSCO
In Semis, Morgan Stanley recommends taking profits in Maxim, Cypress
Morgan Stanley analyst Craig Hettenbach noted he is getting more questions on the broader cyclical effects that lead time extensions are having on semiconductor demand. His recent checks and survey work point to steady order trends, but there are some "yellow flags" to watch when assessing cyclical risk, said the analyst, who would add to positions in Analog Devices (ADI), TE Connectivity (TEL) and Microchip (MCHP) and recommends taking profits in Maxim Integrated (MXIM) and Cypress Semiconductor (CY). He keeps Overweight ratings on the first three stocks and Underweight ratings on Maxim and Cypress.
10/19/17
JEFF
10/19/17
NO CHANGE
JEFF
Jefferies sees 'Analog Renaissance,' ups semiconductor price targets
Jefferies analyst Mark Lipacis says that while many investors are concerned about inventories and are taking profits, he expects more consolidation and even higher profitability for analog companies. Analog stocks should also benefit from secular themes and cyclical demand drivers, Lipacis tells investors in a research note titled "Analog Renaissance - Are the Old Semiconductor Investing Tools Broken?" His top "Analog Renaissance" plays are Texas Instruments (TXN), Analog Devices (ADI), Microchip (MCHP) and Maxim Integrated (MXIM). Lipacis raised his price target for Analog Devices to $105 from $100, for Maxim to $58 from $51, for Texas Instruments to $100 from $96, for ON Semiconductor (ON) to $20 from $16 and for Microchip to $106 from $94
08/31/17
NOMU
08/31/17
UPGRADE
Target $80
NOMU
Neutral
Analog Devices upgraded to Neutral from Reduce at Nomura Instinet
Nomura Instinet analyst Romit Shah upgraded Analog Devices to Neutral and raised its price target to $80 from $72.50 following Q3 resutls and guidance. The analyst said Q3 results were "solid" and guidance was based in part on improved profitability. Shah also said the "speedy" appointment of Prashanth Mahendra-Rajah as CFO is a positive as he has a solid track record of driving shareholder value and is well regarded.
DLTR Dollar Tree
$97.11

2.5 (2.64%)

11/03/17
WELS
11/03/17
INITIATION
Target $106
WELS
Outperform
Dollar Tree initiated with an Outperform at Wells Fargo
Wells Fargo analyst Edward Kelly started Dollar Tree with an Outperform rating and $106 price target. The analyst views the stock as an attractive option in the Food & Staples retail universe.
11/14/17
UBSW
11/14/17
NO CHANGE
Target $106
UBSW
Buy
Dollar Tree Q3 results should be stock's next catalyst, says UBS
UBS analyst Michael Lasser said Dollar Tree's Q3 results should be the next catalyst to make more believers of the company. The analyst said the company should see tailwinds from a host of initiatives and from its enhanced buying power helping to drive consistent comp growth and double digit earnings growth and upside in the shares. Lasser reiterated his Buy rating and raised his price target to $106 from $100 on Dollar Tree shares.
11/14/17
GSCO
11/14/17
INITIATION
Target $106
GSCO
Buy
Dollar Tree assumed with a Buy at Goldman Sachs
Goldman analyst Christopher Prykull assumed coverage on Dollar Tree with an Outperform and $106 price target. The analyst believes Dollar Tree is more immune to online given its value focus and convenient locations, with a long runway for new store growth. Prykull believes Dollar Tree's free cash flow story is underappreciated as it enters peak synergy realization from Family Dollar and ramping initiatives including remodels and product refresh.
11/20/17
MKMP
11/20/17
NO CHANGE
Target $96
MKMP
Buy
Dollar General price target raised to $96 from $83 at MKM Partners
MKM Partners analyst Patrick McKeever raised his price target on Dollar General (DG) to $96 and kept his Buy rating ahead of its December 7th earnings, saying both Dollar General and Dollar Tree (DLTR) saw significant comps improvement in the second quarter. McKeever expects more upside going into the holidays as a result of wage gains for the core dollar store customer. The analyst adds that he prefers Dollar General to Dollar Tree due to more attractive valuation as well as his view that its 2.5% SSS forecast may be conservative. McKeever is keeping the latter at Neutral while also raising its price target to $96 from $83.
HRL Hormel Foods
$33.40

0.28 (0.85%)

10/19/17
SPHN
10/19/17
NO CHANGE
Target $38
SPHN
Overweight
Hormel Foods price target lowered to $38 from $50 at Stephens
Stephens analyst Farha Aslam lowered her price target for Hormel Foods to $38 from $50 citing the more challenging U.S. operating environment given changing consumer preferences, price pressures and commodity uncertainty. However, she keeps an Overweight rating on the shares, as she believes the current challenging fundamentals are largely priced into the stock at current levels.
10/31/17
KEYB
10/31/17
INITIATION
KEYB
Sector Weight
Hormel Foods initiated with a Sector Weight at KeyBanc
KeyBanc analyst David Carlson started Hormel Foods with a Sector Weight rating citing a lack of visibility to achieving the company's long-term target of 10% annual earnings growth.
11/03/17
MSCO
11/03/17
INITIATION
Target $26
MSCO
Underweight
Hormel Foods initiated with an Underweight at Morgan Stanley
Morgan Stanley analyst John Colantuoni initiated coverage of the protein producers with a cautious view of the sector, as he sees the risk-reward skewed to the downside with supply/demand imbalances looming. He started Hormel Foods with an Underweight rating, as he expects flat EPS over FY18/FY19 given likely margin pressure in pork and heightened competition in packaged foods. He set a $26 price target on Hormel shares.
11/03/17
11/03/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. YogaWorks (YOGA) initiated with an Outperform at Imperial Capital. 2. IRIDEX (IRIX) resumed with a Buy at Roth Capital. 3. TE Connectivity (TEL) initiated with an Outperform at Baird. 4. Pilgrim's Pride (PPC), Sanderson Farms (SAFM), and Tyson Foods (TSN) were initiated with an Equal Weight at Morgan Stanley, while Hormel Foods (HRL) initiated with an Underweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CPB Campbell Soup
$49.93

0.21 (0.42%)

09/06/17
FBCO
09/06/17
NO CHANGE
Target $43
FBCO
Underperform
Campbell Soup, Wal-Mart still negotiating, says Credit Suisse
Following up on Campbell Soup's (CPB) public disagreement in the soup category with Wal-Mart (WMT), Credit Suisse analyst Robert Moskow says the dispute specifically relates to Wal-Mart's demands for lower everyday price points on Campbell's condensed soup products. While this dispute does not appear to involve General Mills' (GIS) Progresso brand or the ready-to-serve category at this time, the analyst notes that Wal-Mart presumably could threaten to give more shelf space to General Mills or its Great Value brand at Campbell's expense. Campbell and Wal-Mart are still negotiating, Moskow points out, adding that it may be a good thing for the stock if Campbell can get Wal-Mart to agree to a compromise. The analyst reiterates an Underperform rating and $43 price target on Campbell's shares.
09/01/17
GSCO
09/01/17
NO CHANGE
Target $45
GSCO
Neutral
Campbell Soup price target lowered to $45 from $49 at Goldman Sachs
Goldman analyst Jason English lowered Campbell Soup's price target to $45 from $49 and maintained a Neutral rating citing disappointing results and eroding fundamentals. The analyst remains on the sidelines given relative under-performance versus peers and sees risk of multiple compression.
09/01/17
DBAB
09/01/17
NO CHANGE
Target $51
DBAB
Hold
Campbell Soup price target lowered to $51 from $58 at Deutsche Bank
Deutsche Bank analyst Rob Dickerson lowered his price target for Campbell Soup to $51 saying management maintained a relatively cautious tone after missing Q4 consensus estimates. The analyst sees a "number of upcoming headwinds" for the company and notes its 2018 will largely be an investment year. He keeps a Hold rating on Campbell.
09/19/17
PIPR
09/19/17
DOWNGRADE
Target $72
PIPR
Neutral
Kellogg downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Michael Lavery downgraded Kellogg (K) to Neutral saying cereal could be at risk from shrinking center store space. Recent comments by Kroger (KR) and Campbell Soup (CPB) indicate retailer pushback is a real threat to packaged food suppliers, Lavery tells investors in a research note. He adds that scanner data suggests Kellogg's sales trends are worse than expected in both snacks and cereal. The analyst dropped his price target for Kellogg to $72 from $78.
BURL Burlington Stores
$106.55

1.82 (1.74%)

08/15/17
WELS
08/15/17
NO CHANGE
WELS
TJX results bode well for off-price sector, says Wells Fargo
Wells Fargo analyst Ike Boruchow says that TJX's (TJX) better than expected Q2 results bode well for the off-price retail sector. The analyst notes that the company's merchandise margins rebounded in Q2, even though its overall gross margins came in below expectations due to "losses on inventory hedges," Other companies in the sector include Ross Stores, (ROST) and Burlington Stores (BURL). The analyst keeps Outperform ratings on all three stocks.
08/08/17
BMOC
08/08/17
NO CHANGE
BMOC
Burlington Stores weakness creates buying opportunity, says BMO Capital
BMO Capital analyst John Morris says that Burlington's recent weakness has created a buying opportunity. Morris says that worries about lack of off-price supply are overdone, while the company should benefit from expansion into health and beauty categories.
09/14/17
DBAB
09/14/17
INITIATION
Target $108
DBAB
Buy
Burlington Stores initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Mike Baker started Burlington Stores with a Buy rating and $108 price target. The analyst believes the off price model is taking share in apparel retailing and that Burlington's earnings power relative is higher than consensus estimates suggest.
10/19/17
BUCK
10/19/17
INITIATION
Target $107
BUCK
Buy
Burlington Stores assumed with a Buy at Buckingham
Buckingham analyst Eric Tracy assumed coverage on Burlington Stores with a Buy and $107 price target.
SIG Signet Jewelers
$75.84

-0.74 (-0.97%)

08/25/17
WELS
08/25/17
NO CHANGE
WELS
Signet Jewelers price target raised to $75 from $70 at Wells Fargo
Wells Fargo analyst Ike Boruchow increased its price target on Signet as he says that the company's Q2 results "appear to be a major step in the right direction." The analyst thinks that the company's fundamentals are "stabilizing." He keeps an Outperform rating on the shares.
11/14/17
BUCK
11/14/17
NO CHANGE
Target $72
BUCK
Neutral
Signet Jewelers price target raised to $72 from $55 at Buckingham
Buckingham analyst Scott Krasik raised his price target on Signet Jewelers shares to $72 from $55 citing his more favorable view of management and new CEO Virginia Drosos, easier comparisons this holiday and the stabilization of jewelry industry sales. He keeps a Neutral rating on the stock, but said he would look to take a more positive view once there is some visibility on the company being able to pull back on promotions and a line of sight to the resolution of the next phase of its credit review process.
11/02/17
11/02/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tabula Rasa HealthCare (TRHC) initiated with an Overweight at First Analysis. 2. HollyFrontier (HFC) reinstated with an Overweight at Barclays. 3. Medidata (MDSO) initiated with a Neutral at Dougherty. 4. Tiffany (TIF) and Signet Jewelers (SIG) were initiated with a Neutral at Susquehanna, while Tapestry (TPR) and Michael Kors (KORS) were initiated with a Positive. 5. Prometic Life Sciences (PFSCF) initiated with an Overweight at Cantor Fitzgerald. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/02/17
SUSQ
11/02/17
INITIATION
Target $60
SUSQ
Neutral
Signet Jewelers initiated with a Neutral at Susquehanna
Susquehanna analyst Bill Dreher initiated Signet Jewelers with a Neutral rating as he remains cautious following its recent results, which have been challenged and choppy. Dreher has a $60 price target on Signet Jewelers shares.
DSW DSW
$22.53

0.38 (1.72%)

11/02/17
11/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Square (SQ) downgraded to Hold from Buy at Stifel with analyst Scott Devitt citing valuation for the rating change and upped his price target for the shares to $36 from $29. 2. Papa John's (PZZA) downgraded to Neutral from Buy at BTIG with analyst Peter Saleh citing an uncertain sales outlook, increased competitive pressures, and modest earnings growth near-term. 3. Newell Brands (NWL) downgraded to Neutral from Overweight at JPMorgan with analyst Andrea Teixeira citing the company's third quarter miss and lowered fiscal 2017 guidance. This marks the second time in two months Newell lowered its outlook, Teixeira tells investors in a post-earnings research note. 4. Oclaro (OCLR) downgraded to Buy from Strong Buy at Needham and to Hold from Buy at Craig-Hallum. 5. DSW (DSW) downgraded to Neutral from Buy at B. Riley FBR with analyst Jeff Van Sinderen saying the multi-year fashion shift away from boots is intensifying, and is being made worse by warmer weather. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/16/17
SUSQ
11/16/17
UPGRADE
SUSQ
Positive
DSW upgraded to Positive from Neutral at Susquehanna
11/16/17
SUSQ
11/16/17
UPGRADE
Target $23
SUSQ
Positive
DSW upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Sam Poser upgraded DSW to Positive from Neutral. The analyst cited momentum in the core women's business and well-controlled inventory levels, which suggest positive inflections are at hand. He believes the implementation and integration of company-wide planning systems and tools will lead to improved results. Poser raised his price target to $23 from $21 on DSW shares.
11/16/17
11/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pandora (P) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying that despite the lack of near-term catalysts, the market underappreciates longer-term factors. 2. Dollar General (DG) upgraded to Buy from Hold at Deutsche Bank with analyst Paul Trussell saying Dollar General's "long-term profit algorithm" will return in 2018. 3. RH (RH) upgraded to Buy from Neutral at Citi with analyst Geoffrey Small saying the company's initial outlook for 2018 alleviates concerns around the balance sheet and uncertainty regarding demand as the retailer backed off of elevated levels of sales and promotions. 4. Regions Financial (RF) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Ryan Nash saying he sees better than expected net interest margin, improving loan growth and increased capital returns helping Regions reach its efficiency goals in 2018. 5. DSW (DSW) upgraded to Positive from Neutral at Susquehanna with analyst Sam Poser citing momentum in the core women's business and well-controlled inventory levels, which suggest positive inflections are at hand. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NXPI

NXP Semiconductors

$115.64

-0.2 (-0.17%)

, QCOM

Qualcomm

$64.86

-0.32 (-0.49%)

08:05
12/13/17
12/13
08:05
12/13/17
08:05
Hot Stocks
Breaking Hot Stocks news story on NXP Semiconductors, Qualcomm »

Elliott's UBS report…

NXPI

NXP Semiconductors

$115.64

-0.2 (-0.17%)

QCOM

Qualcomm

$64.86

-0.32 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

DRRX

Durect

$0.98

-0.0259 (-2.56%)

08:04
12/13/17
12/13
08:04
12/13/17
08:04
Hot Stocks
Durect announces NDA acceptance of Indivior's RBP-7000 risperidone monthly depot »

Durect announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHFS

CHF Solutions

$3.58

-0.22 (-5.79%)

08:04
12/13/17
12/13
08:04
12/13/17
08:04
Hot Stocks
CHF Solutions signs distribution, services agreement with TRANSMEDIC »

CHF Solutions announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FATE

Fate Therapeutics

$4.44

0.295 (7.13%)

08:04
12/13/17
12/13
08:04
12/13/17
08:04
Syndicate
Fate Therapeutics 9.525M share Spot Secondary priced at $4.20 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 13

    Dec

CAPR

Capricor Therapeutics

$1.60

-0.1 (-5.88%)

08:03
12/13/17
12/13
08:03
12/13/17
08:03
Hot Stocks
Capricor Therapeutics announces issuance of key patent on exosome technology »

Capricor Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFIN

Medallion Financial

$3.14

0.04 (1.29%)

08:03
12/13/17
12/13
08:03
12/13/17
08:03
Hot Stocks
Medallion Bank closes sale of $127M in consumer loan recievables »

Medallion Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXPI

NXP Semiconductors

$115.64

-0.2 (-0.17%)

, QCOM

Qualcomm

$64.86

-0.32 (-0.49%)

08:01
12/13/17
12/13
08:01
12/13/17
08:01
Hot Stocks
Elliott: UBS report supports view that NXP's value in excess of Qualcomm offer »

Elliott Advisors, which…

NXPI

NXP Semiconductors

$115.64

-0.2 (-0.17%)

QCOM

Qualcomm

$64.86

-0.32 (-0.49%)

AVGO

Broadcom

$258.70

-1.25 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 06

    Mar

HXL

Hexcel

$60.98

1.64 (2.76%)

08:01
12/13/17
12/13
08:01
12/13/17
08:01
Recommendations
Hexcel analyst commentary  »

Hexcel price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTLT

Catalent

$39.54

-0.2 (-0.50%)

08:00
12/13/17
12/13
08:00
12/13/17
08:00
Initiation
Catalent initiated  »

Catalent initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:00
12/13/17
12/13
08:00
12/13/17
08:00
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

TSM

TSMC

$39.30

-0.07 (-0.18%)

07:57
12/13/17
12/13
07:57
12/13/17
07:57
Periodicals
TSMC chairman says HPC chip demand remains strong, DigiTimes reports »

TSMC (TSM) chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$26.33

-0.25 (-0.94%)

07:56
12/13/17
12/13
07:56
12/13/17
07:56
Conference/Events
Kroger management to meet with Deutsche Bank »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

ST

Sensata

$51.66

3.76 (7.85%)

07:55
12/13/17
12/13
07:55
12/13/17
07:55
Recommendations
Sensata analyst commentary  »

Sensata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$15.70

-0.17 (-1.07%)

, FTR

Frontier Communications

$10.05

-0.01 (-0.10%)

07:55
12/13/17
12/13
07:55
12/13/17
07:55
Recommendations
CenturyLink, Frontier Communications, Windstream analyst commentary  »

Morgan Stanley says…

CTL

CenturyLink

$15.70

-0.17 (-1.07%)

FTR

Frontier Communications

$10.05

-0.01 (-0.10%)

WIN

Windstream

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNM

Unum Group

$56.40

-0.25 (-0.44%)

07:55
12/13/17
12/13
07:55
12/13/17
07:55
Conference/Events
Unum Group to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HON

Honeywell

$153.74

0.53 (0.35%)

07:55
12/13/17
12/13
07:55
12/13/17
07:55
Conference/Events
Honeywell to hold a conference call »

Management provides 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

JLL

Jones Lang LaSalle

$149.76

0.56 (0.38%)

07:55
12/13/17
12/13
07:55
12/13/17
07:55
Conference/Events
Jones Lang LaSalle to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AAPL

Apple

$171.70

-0.97 (-0.56%)

07:52
12/13/17
12/13
07:52
12/13/17
07:52
Periodicals
Apple hires Matthys, Grazier for business affairs on content team, Variety says »

Apple has hired Philip…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$52.69

0.61 (1.17%)

07:51
12/13/17
12/13
07:51
12/13/17
07:51
Syndicate
TD Ameritrade 27.7M share Spot Secondary priced at $51.50 »

Goldman Sachs acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUBS

HubSpot

$82.70

-0.7 (-0.84%)

07:50
12/13/17
12/13
07:50
12/13/17
07:50
Conference/Events
HubSpot management to meet with Needham »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

VZ

Verizon

$53.19

1.35 (2.60%)

07:50
12/13/17
12/13
07:50
12/13/17
07:50
Conference/Events
Verizon management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CRL

Charles River

$104.57

0.67 (0.64%)

07:50
12/13/17
12/13
07:50
12/13/17
07:50
Initiation
Charles River initiated  »

Charles River initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAY

Verifone

$18.47

0.28 (1.54%)

07:50
12/13/17
12/13
07:50
12/13/17
07:50
Technical Analysis
Technical View: Verifone falls after earnings and outlook disappoint »

In premarket trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

FRED

Fred's

$3.77

-0.19 (-4.80%)

07:49
12/13/17
12/13
07:49
12/13/17
07:49
Conference/Events
Fred's management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NICE

Nice

$87.71

0.03 (0.03%)

07:47
12/13/17
12/13
07:47
12/13/17
07:47
Recommendations
Nice analyst commentary  »

Nice price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.